Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chondrosarcoma × Chloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Glioblastoma 4 Small Cell Lung Carcinoma 2 Breast Neoplasms 2 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Gliosarcoma 1 Glioma 1 Chondrosarcoma 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Ifosfamide 5 Filgrastim 5 Doxorubicin 5 Docetaxel 4 Radiotherapy 3 Proton Therapy 3 Gemcitabine 3 Carboplatin 3 regorafenib 2 ivosidenib 2 enasidenib 2 belinostat 2 Sunitinib 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Immune Checkpoint Inhibitors 2 HhAntag691 2 Fluorouracil 2 Etoposide 2 Epirubicin 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 Celecoxib 2 Bevacizumab 2 venetoclax 1 toripalimab 1 temsirolimus 1 tazemetostat 1 tanespimycin 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡